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Abstract
Forkhead transcription factors of the FoxO subfamily regulate gene expression programs downstream of the insulin
signaling network. It is less clear which proteins mediate transcriptional control exerted by Target of rapamycin (TOR)
signaling, but recent studies in nematodes suggest a role for FoxA transcription factors downstream of TOR. In this study we
present evidence that outlines a similar connection in Drosophila, in which the FoxA protein Fork head (FKH) regulates
cellular and organismal size downstream of TOR. We find that ectopic expression and targeted knockdown of FKH in larval
tissues elicits different size phenotypes depending on nutrient state and TOR signaling levels. FKH overexpression has a
negative effect on growth under fed conditions, and this phenotype is not further exacerbated by inhibition of TOR via
rapamycin feeding. Under conditions of starvation or low TOR signaling levels, knockdown of FKH attenuates the size
reduction associated with these conditions. Subcellular localization of endogenous FKH protein is shifted from
predominantly cytoplasmic on a high-protein diet to a pronounced nuclear accumulation in animals with reduced levels
of TOR or fed with rapamycin. Two putative FKH target genes, CG6770 and cabut, are transcriptionally induced by rapamycin
or FKH expression, and silenced by FKH knockdown. Induction of both target genes in heterozygous TOR mutant animals is
suppressed by mutations in fkh. Furthermore, TOR signaling levels and FKH impact on transcription of the dFOXO target
gene d4E-BP, implying a point of crosstalk with the insulin pathway. In summary, our observations show that an alteration of
FKH levels has an effect on cellular and organismal size, and that FKH function is required for the growth inhibition and
target gene induction caused by low TOR signaling levels.
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Introduction
Transcription factors belonging to the winged helix/forkhead box
(Fox) family are implicated in a variety of biological processes
ranging from embryonic development to the regulation of
metabolism, growth, cell death and organismal lifespan [1].
Members of this transcription factor family share a conserved 110-
residue DNA binding domain first discovered in the Drosophila
Fork Head protein, which therefore and because of structural
reasons is referred to as the forkhead or winged helix domain. The
family is divided into subclasses labeled with the letters A to S, and
this categorization is based on amino acid sequence similarity in
the forkhead domain [2]. For most Fox proteins, knowledge is
scarce about how they are interfaced with upstream signaling
pathways. A well characterized group is the FoxO subfamily
which, among input from other pathways, is regulated by the
insulin signaling module in a way that is conserved between the
nematode Caenorhabditis elegans and humans. This involves direct
phosphorylation by insulin-induced kinases, binding to 14-3-3
proteins and nucleocytoplasmic shuttling [3]. The insulin-forkhead
connection was first described in C. elegans, where mutations in the
insulin receptor gene daf-2 are completely suppressed by mutations
in the FoxO transcription factor gene daf-16 [4,5]. Members of the
FoxA subfamily are also important players in metabolism and
regulated by insulin, but whether the exact mechanism also
involves nuclear exclusion is still a matter of debate and less clear
than for FoxO proteins [6]. Once again, pioneering research in C.
elegans started to uncover a link between a growth control pathway
and a forkhead transcription factor, this time between the worm
Target of rapamycin (TOR) homolog LET-363 and the FoxA
protein PHA-4. The first study in this line of evidence described
the longevity of worms with reduced levels of TOR signaling. In
contrast to the daf-16-dependent lifespan increase of insulin
receptor mutant worms, long life conferred by low levels of
TOR is not affected by daf-16 mutations [7]. This suggested that
insulin and TOR signaling regulate lifespan through distinct
downstream transcriptional regulators. Another condition which,
similar to reduced TOR signaling, can prolong life in nematodes
in a DAF-16-independent fashion is dietary restriction. LET-363 is
involved in the dietary restriction response induced by mutations
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pharyngeal pumping [8], or in pep-2 mutants which display
compromised intestinal uptake of dietary peptides [9]. PHA-4 was
recently identified as the forkhead transcription factor which is
necessary to increase lifespan under multiple conditions of dietary
restriction, such as lowering the concentration of bacteria fed to
the worms in culture or eat-2 mutations, but not under conditions
of lowered insulin signaling [10], making it a candidate for a
transcriptional effector downstream of TOR signaling. This
working hypothesis was confirmed by the finding that PHA4 is
required for the lifespan extension elicited by reduced LET-363/
TOR or RSKS-1/S6 kinase levels, both of which are independent
of DAF-16 function [11]. These observations prompted us to
investigate a possible link between TOR signaling and the
transcription factor Fork head (FKH), which among the 18
Drosophila forkhead proteins is the only one belonging to the FoxA
subfamily [12]. Here we present evidence that in addition to its
established role in embryonic development and regulation of
salivary gland cell death in the larva, FKH controls cell and
organismal size, that its subcellular localization is regulated by
TOR signaling and that it is necessary for the expression of
rapamycin- and starvation-responsive genes as well as for
rapamycin-induced inhibition of growth. For the first time in
Drosophila, we describe an interaction between TOR and a FoxA
protein, which is in agreement with the observations made in C.
elegans. In addition, our findings yield novel insights about the
regulation of growth by FKH, and how FKH and dFOXO are
partially redundant in the regulation of d4E-BP expression.
Results
Alteration of FKH levels elicits organism and cell size
phenotypes which are sensitive to nutrient conditions
and TOR signaling
As in other organisms, TOR signaling in Drosophila is involved in
the nutrient-dependent regulation of cellular and organismal
growth [13,14]. We therefore first asked whether an alteration of
FKH levels in vivo would have an effect on growth. As homozygous
fkh mutants are embryonic lethal [15], we applied the GAL4/UAS
system to either knock down FKH in larval tissues by RNA
interference or to raise FKH levels by ectopic overexpression, each
under different nutrient conditions. As shown in Figure 1,
overexpression of FKH in the larval fatbody induced by the
pumpless driver causes a severe reduction in body size (Figure 1I
and K), similar to the one resulting from TOR inhibition induced
by rearing the larvae on rapamycin-containing food (Figure 1B).
Rapamycin does not significantly further reduce the size of FKH-
overexpressing animals (Figure 1J). Moderate ubiquitous RNAi
knockdown of FKH with the armadillo driver leads to a slight
decrease in larval size under fed conditions (Figure 1E). Rapamy-
cin feeding causes a reduction in larval size via inhibition of TOR
signaling. However, this phenotype is less strong in animals with
repressed FKH levels (Figure 1F and K), suggesting that FKH is
required for rapamycin-induced growth inhibition. Expression of a
negative control inverted repeat directed against lacZ had no
significant impact on larval size under both conditions (Figure 1C,
D and K), ruling out unspecific effects of double-stranded RNA
expression. Likewise, ectopic expression of b-galactosidase in
UAS-lacZ control animals had no effect on larval size (Figure 1G,
H and K). Quantitative realtime PCR was performed to measure
the efficiency of fkh knockdown by RNAi in this experimental
setup, and fkh transcript levels were found to be reduced by 60%
compared to wildtype larvae (Figure S1).
In a second set of experiments, we analyzed the effect of FKH
overexpression or knockdown on cell size. The ‘FLP-out’ system
[16] was used to overexpress or silence FKH in cell clones in the
larval fatbody. The effects on cell size were similar to those on
organismal size and are displayed in Figure 2, the quantitative and
statistical analysis of cell size phenotypes is shown in Figure 3. For
each genotype and condition, we compared the size of transgene-
expressing cells which are marked by the co-expression of nuclear
green fluorescent protein (GFP) to the size of the non-fluorescent
wild-type cells within the same tissue sample. Cells overexpressing
FKH are significantly smaller than wild-type cells in fed animals
(Figure 2J and 3B) but not in starved larvae (Figure 2K and 3B). In
rapamycin-fed larvae, clonal FKH expression slightly reduced cell
size, but to a much lesser extent compared to yeast-fed animals
(Figure 2L and 3B). This indicates that cells are most susceptibe to
growth inhibition by ectopic FKH expression under conditions of
dietary protein abundance and active TOR signaling. Conversely,
RNAi-induced silencing of FKH expression in cell clones had no
significant effect on cell size in fatbodies of fed larvae (Figure 2D
and 3A), but under conditions of starvation or rapamycin feeding,
FKH knockdown elicited increased cell growth compared to
control cells within the same tissue (Figure 2E, F and 3A). The
observation that cells with low FKH levels are larger than the
neighboring wild-type cells in tissues subjected to starvation or
TOR inhibition supports the model that FKH is required for the
inhibition of growth in response to these conditions. As in the
larval body size experiments described above, fat body cell size was
unaffected by clonal expression of the negative control constructs
UAS-lacZ-RNAi (Figure 2D–F and 3A) or UAS-lacZ (Figure 2J–L
and 3B). In this experimental setup, the FKH phenotypes observed
correspond qualitatively to those of negatively regulating TOR
signaling components. As shown in Figure S4, co-expression of
TSC1 and TSC2 [17], negative upstream regulators of TOR,
strongly reduces cell size in feeding larvae, while the size reduction
is much less pronounced in starved animals. Conversely,
expression of the small GTPase Rheb, which activates TOR
signaling, leads to a mild cell size increase under conditions of
nutrient abundance and to a stronger one under starvation, as has
been reported previously [18,19].
Subcellular localization of FKH depends on nutrient and
TOR signaling levels
In the next step, we sought to investigate whether nutrient or
TOR signaling levels have an influence on the subcellular
localization of FKH protein. To monitor localization of the
endogenous protein in tissues, we generated an affinity-purified
polyclonal antibody against FKH. To ascertain the specificity of
the new tool, western blot and immunohistochemical control
experiments were performed which showed that the antibody
could be used to detect endogenous as well as transgenically
encoded FKH protein in larval extracts with very little unspecific
background (Figure S2A). Furthermore, immunostainings visual-
ized endogenous and overexpressed epitope-tagged FKH protein,
and it could be observed that the main nuclear signal recognized
by the antibody is indeed FKH (Figure S2B–E). Based on these
control experiments, we then analyzed endogenous FKH
localization in the larval fatbody under conditions of different
nutrient and TOR signaling levels. When larvae were fed yeast
paste, which contains a higher fraction of dietary proteins and
amino acids compared to sugar-cornmeal-based fly food [20,21],
FKH was found to be localized in the cytoplasm of fatbody cells
and almost completely excluded from the nuclei (Figure 4A, B and
4E, F). In larvae starved on PBS, nuclear exclusion was not
observed, and the contours of the nuclei were not visible due to the
Regulation of Drosophila FKH/FOXA by TOR
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high-protein diet (Figure 4I, J). Significant nuclear accumulation
did not occur either, but the protein was rather evenly distributed
within the cells. It should be noted that under this starvation
condition, dFOXO shows a strong nuclear localization (Figure 4K,
L). In contrast to the condition of complete starvation, in fatbodies
from rapamycin-fed (Figure 4C, D) or heterozygous TOR mutant
larvae (Figure 4G, H), FKH was localized predominantly nuclear,
although a prominent cytoplasmic signal remained detectable.
This suggests that TOR activity is required to keep FKH protein
sequestered in the cytoplasm under conditions of dietary protein
abundance. Importantly, this effect of TOR signaling on FKH
localization was only observed on the endogenous protein. In
contrast, overexpressed FKH was found to be constitutively
nuclear in the larval fatbody (Figure S2B–E) as well as in cultured
S2R+ cells (Figure S2F–K) even under conditions of nutrient
abundance and high insulin/TOR signaling levels.
The expression of cabut and CG6770 is regulated by FKH
and TOR signaling
In an attempt to establish quantitative molecular readouts
which may be used to monitor FKH activity under conditions of
normal or impaired TOR signaling, we screened published
transcriptomic datasets for Drosophila genes which are regulated
by nutrient availability, rapamycin or forkhead transcription
factors in several independent experiments. The gene cabut
encodes a C2H2 zinc finger transcription factor which is
conserved between species (the yeast ortholog is FZF1, human
ortholog is KLF11), plays a role in JNK-dependent dorsal closure
in the Drosophila embryo [22] and was previously identified in
screens for genes involved in axon guidance and synaptogenesis
[23] as well as autophagic cell death [24]. cabut caught our interest
because it was found to be transcriptionally upregulated by
rapamycin in S2 cells, and RNAi knockdown of the gene lead to
increased cell size and proliferation [25]. It therefore is a
Figure 1. FKH levels influence larval body size. Pictures show 72 h old larvae (62h) which were treated at 24 h after egg deposition (AED) with
0( A, C, E, G, I)o r5 0mM( B, D, F, H, J) rapamycin for 48 h. A, B: OregonR wildtype control. C, D: y w UAS-LacZ-RNAi; arm-Gal4/+. Treating control
larvae with 50 mM rapamycin leads to severe reduction of growth. E, F: w; arm-Gal4/+; UAS-FKH-RNAi/+. Untreated larvae are slightly smaller than
controls, but size reduction by rapamycin feeding is less pronounced in larvae with low FKH levels. G, H: w;; ppl-Gal4/UAS-LacZ.I ,J :w;; ppl-Gal4/UAS-
FKH. Overexpression of FKH leads to a severe reduction in body size similar to that resulting from rapamycin feeding. At 25uC, overexpression
furthermore leads to larval lethality in the 2
nd instar. Rapamycin feeding of FKH-overexpressing larvae has almost no additive effect to the reduction
in body size. (K) Quantitation of larval body size shows that rapamycin-treated larvae with low FKH levels are significantly larger than control larvae
and that untreated larvae with high FKH levels are significantly smaller than control larvae. Significance was tested using an unpaired 2-tailed
Student’s t-test. ***=p,0.001. Error bars represent standard error of the mean (SEM).
doi:10.1371/journal.pone.0015171.g001
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complex 1. It was also identified as being transcriptionally
repressed by a hs-fkh transgene in late prepupae [26] and strongly
induced by sugar condition (protein deprivation) in feeding larvae,
but not by complete starvation [27]. Expression of an active
dFOXO mutant in S2 cells leads to a moderate induction of cabut
expression, while refeeding in adult flies has a weak repressing
effect [28]. The CG6770 gene was first identified as a
transcriptional target of starvation in Drosophila larvae, encoding
a protein with vague similarity to the pancreatic P8 transcriptional
regulator from mouse and human. Expression was induced by
both sugar condition and complete starvation, similar to the
dFOXO target gene d4E-BP [27]. In agreement with these results,
CG6770 was found to be transcriptionally repressed by refeeding
after starvation in adult Drosophila flies and moderately induced by
expression of activated dFOXO in S2 cells [28]. It was
furthermore identified as a negative regulator of cell size in a
genome-wide RNAi screen [29]. We first tested whether the
transcription of cabut and CG6770 is dependent on FKH levels.
The driver lines used were the same as in the larval size
experiments (Figure 1), that is armadillo-GAL4 for targeted RNAi
and pumpless-GAL4 for ectopic expression. RNAi knockdown of
FKH caused a significant decrease of cabut and CG6770 mRNA in
larval extracts, while FKH overexpression induced the transcrip-
tion of both genes (Figure 5A). The induction of CG6770 was
several fold higher than that of cabut. We further validated the
Figure 2. FKH levels influence cell size in the larval fatbody. Pictures show confocal sections of larval fatbodies, using the fly line y w hs-flp;;
Act.CD2.Gal4 UAS-GFP to drive UAS-FKH-RNAi, overexpression and control responder lines. Cells expressing the transgene are marked by the co-
expression of GFP, whereas the non-fluorescent serve as wild-type controls within the same tissue sample. Larvae were reared on yeast for 64 h AED,
or starved on PBS for 24 h after growing on yeast for 64 h, or treated with rapamycin for 24 h after growing on yeast for 48 h. Tissue was stained with
a-GFP (green), a-CD2 (red) and DAPI (blue). (A–C, G–I) Controls show no obvious phenotype in the GFP-positive cells. (D–F) Cells expressing FKH
RNAi have no growth phenotype under fed conditions, but are larger than the surrounding tissue in starved and rapamycin-treated larvae. (J–L) Cells
overexpressing FKH are smaller than the surrounding tissue under fed conditions.
doi:10.1371/journal.pone.0015171.g002
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gene experiment. When a 880 bp PCR product encompassing the
CG6770 promoter was cloned upstream of a luciferase ORF,
reporter gene induction could be achieved from the resulting
plasmid by co-expression of FKH to a greater extent than by
dFOXO (Figure S3). We are aware of the fact that these
observations do not exclude the possibility that cabut and CG6770
are indirect FKH target genes, however we consider this of little
relevance for their use as indicators for FKH activity. In a next
step following the demonstration that both genes are induced by
FKH, we addressed whether cabut and CG6770 transcription was
also responsive to TOR signaling levels, and could thus be used as
a readout to confirm the interaction between the TOR module
and FKH. Rapamycin feeding elicited a robust induction of cabut
Figure 3. Quantitation of the cell size phenotypes shown in figure 2. Cell size was analyzed by measuring the cell perimeter with the
software ImageJ. Blue bars represent the GFP-negative wild-type cells, red bars represent the cells expressing the transgene. Larvae were fed with
yeast paste, starved on PBS or treated with 50 mM rapamycin. (A) Effect of FKH knockdown on cell size. Larvae were of the genotype y w hs-flp;;
Act.CD2.Gal4 UAS-GFP/UAS-FKH-RNAi (bars labeled ‘‘FKH-RNAi’’) or y w hs-flp;; Act.CD2.Gal4 UAS-GFP/UAS-LacZ-RNAi (bars labeled ‘‘LacZ-RNAi’’)
as an unspecific control. Cells expressing FKH dsRNA are significantly larger than the surrounding tissue in larvae which were starved on PBS or
treated with rapamycin. (B) Effect of FKH overexpression on cell size. Larvae were of the genotype y w hs-flp;; Act.CD2.Gal4 UAS-GFP/UAS-FKH (bars
labeled ‘‘UAS-FKH’’) or y w hs-flp;; Act.CD2.Gal4 UAS-GFP/UAS-LacZ (bars labeled ‘‘UAS-LacZ’’) as an unspecific control. Cells which overexpress FKH
are significantly smaller than the surrounding tissue in fed larvae, but not in larvae starved on PBS. They are also significantly smaller than wild-type
cells in larvae treated with rapamycin. Significance was tested using an unpaired 2-tailed Student’s t-test. *=p,0.05; **=p,0.01; ***=p,0.001.
Error bars represent SEM. Because the larvae are not age-matched across the different conditions (see Materials and Methods), we base our
statements on the comparison of transgene-expressing cells to the wild-type control cells within the same sample, and not on the comparison of
absolute cell sizes across different conditions.
doi:10.1371/journal.pone.0015171.g003
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of both genes was likewise elevated in heterozygous and
homozygous TOR mutant larvae (Figure 6B). The highest levels
of CG6770 expression, which apparently is more sensitive to TOR
signaling levels than cabut expression, were measured in rapamy-
cin-fed larvae which also expressed transgenic FKH (Figure 5C),
although the difference in CG6770 transcript levels to the FKH-
expressing larvae without rapamycin is not significant.
FKH is required for the response to rapamycin and
lowered TOR levels
Based on the observations described above, we addressed
whether FKH plays a functional role of physiological relevance
downstream of TOR. Several lines of evidence indicate that FKH
is required for the induction of cabut and CG6770 as well as for
growth inhibition under conditions of low TOR signaling. First,
target gene mRNA levels in FKH-RNAi larvae fed with
rapamycin were lower than in wild-type or lacZ-RNAi control
animals subjected to the same treatment (Figure 6A), indicating
that FKH function is required for full expression of both genes
upon TOR inhibition. However, both genes still appear to be
induced by rapamycin in FKH-RNAi larvae, because FKH
knockdown also reduces basal cabut and CG6770 transcript levels
in the absence of rapamycin. Second, larvae with reduced FKH
levels were less susceptible to growth inhibition by rapamycin
(Figure 1B and F). Likewise, individual cells in which FKH
expression was silenced had a growth advantage over the
neighboring wildtype cells under conditions of starvation or
TOR inhibition (Figures 2 and 3). Third, the augmented
transcription of CG6770 and cabut in heterozygous TOR mutant
larvae was reversed to wild-type levels in double mutant animals
carrying a single copy of the fkh
1 or the fkh
6 loss-of-function allele
[15] in addition to the TOR mutation (Figure 6B). Fourth,
presence of the fkh
1 allele significantly increased the body weight of
adult flies heterozygous for a TOR mutation (Figure 6C). Taken
together, these results demonstrate that FKH function is required
in vivo for the inhibition of organismal and cellular growth and the
induction of target gene transcription under conditions of low
TOR pathway activity.
Impact of FKH and TOR on the expression of the dFOXO
target d4E-BP
Finally, we investigated the convergence of transcriptional
regulation downstream of the insulin and TOR signaling modules.
More specifically, we measured the impact of FKH and TOR
signaling on the expression of the dFOXO target gene d4E-BP/
Thor. The O subfamily forkhead transcription factor dFOXO is
negatively regulated by insulin signaling and activates transcription
Figure 4. Subcellular localization of FKH is modulated by nutrient availability and TOR signaling. Confocal sections of larval fatbody are
shown. For each section, one panel shows only the signal derived from the FKH or dFOXO antibody in green, and a second panel an additional
nuclear counterstain with DAPI pseudo-colored in red. (A, B) FKH is excluded from the nucleus in fatbodies of wildtype 2
nd instar larvae fed on yeast.
(C, D) FKH accumulates in the nucleus in fatbodies of wildtype larvae treated with 50 mM rapamycin. (E, F) Closeup of A, B. (G, H) FKH is nuclear in
heterozygous TOR mutants (y w; dTOR
DP/+). (I, J) Nuclear exclusion of FKH is not observed in larvae subjected to starvation on PBS. (K, L) In contrast
to FKH, dFOXO shows a clear nuclear localization in wildtype larvae starved on PBS. Scale bar is 20 mm.
doi:10.1371/journal.pone.0015171.g004
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conditions of nutrient scarcity [30,31]. Rapamycin was found to
induce transcription of d4E-BP in larvae, whereas RNAi-knock-
downofFKHlead toasignificantdecreaseofexpressionunderboth
conditions. Conversely, overexpression of FKH elicited a strong
elevation of d4E-BP mRNA levels (Figure 7A). Similar to the effect
on CG6770 and cabut, TOR-mutant larvae displayed increased d4E-
BP transcription, whichwascompletely suppressed bythe fkh
1 orthe
fkh
6 mutation (Figure 7B). These results suggest that induction of
d4E-BP transcription is not only mediated by dFOXO under
conditions of starvation and low insulin signaling, but also by FKH
when TOR signaling levels are low.
Discussion
In C. elegans, the FoxA transcription factor PHA-4 has been
identified as a mediator of TOR signaling in the regulation of
lifespan. In this study, we present a characterization of the fly
FoxA protein FKH in the biological context of TOR-regulated
growth and gene transcription. Figure 8 shows a simplified
schematic representation of the working model which we propose
based on our experimental results, describing FKH as a mediator
of the cellular response to protein deprivation.
As FKH has been previously uncharacterized in terms of
growth control, we first established that alterations of FKH levels
lead to changes in cellular and organismal size. Ectopic expression
of FKH reduced growth of feeding larvae and of fatbody cells
under conditions of nutrient abundance, and induced expression
of the rapamycin-sensitive genes CG6770 and cabut. The
observation that FKH overexpression phenotypes are strongest
under conditions of dietary protein abundance and active TOR
signaling might reflect a scenario in which the abundance of
upstream negative regulators of FKH is limiting under these
conditions. Thus an experimental elevation of FKH protein levels
would override the endogenous upstream signaling systems and
elicit an inhibition of growth. As discussed below, the same
argumentation could explain the finding that in contrast to the
endogenous protein, overexpressed FKH accumulates in the
nucleus even on a high-protein diet. The same three readouts
were used to demonstrate that FKH function is required for
growth inhibition downstream of TORC1. Targeted knockdown
of FKH by RNAi diminished the decrease in larval size, fatbody
cell size as well as the induction of rapamycin target gene
expression when TOR signaling activity was lowered. The
elevated transcription of CG6770, cabut and d4E-BP in heterozy-
gous TOR mutants was likewise suppressed by fkh loss-of-function
Figure 5. Transcription of CG6770 and cabut is regulated by FKH and rapamycin. Realtime qPCR was performed to quantify mRNAs in larval
extracts. (A) Compared to wildtype animals, the putative FKH targets CG6770 and cabut are downregulated in yeast-fed larvae with low FKH levels (w;
arm-Gal4/+; UAS-FKH-RNAi/+) and upregulated in larvae overexpressing FKH (w;; ppl-Gal4/UAS-FKH). (B) CG6770 and cabut transcription is induced in
wildtype larvae fed with 50 mM rapamycin. (C) CG6770 and cabut mRNA levels are significantly elevated upon rapamycin treatment and in larvae with
high FKH levels in comparison to the wildtype and unspecific controls (w;; ppl-Gal4/UAS-LacZ). Rapamycin treatment of larvae with high FKH levels
has no significant additive effect on target gene expression. Significance was tested using an unpaired 2-tailed Student’s t-test. *=p,0.05;
**=p,0.01; ***=p,0.001. Error bars represent SEM.
doi:10.1371/journal.pone.0015171.g005
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ference experiments.
In addition to its function in the regulation of TOR-dependent
growth and gene expression, we investigated the impact of nutrient
levels and TOR signaling on the subcellular localization of FKH. On
a protein-rich-diet, FKH was excluded from the nucleus in larval
fatbody tissue, and inhibition of TOR signaling by pharmacological
or genetic means elicited a robust nuclear translocation of the
transcription factor. Starvation induced by complete nutrient
deprivation on PBS only had a weak effect on FKH localization,
diminishing nuclear exclusion to the point that the contours of the
nuclei, which were visible due to the absence of nuclear signal in the
yeast feeding condition, were no longer discernible. Albeit weak, we
believe that this increase in nuclear localization is biologically
relevant, as FKH function is required for the starvation-induced
attenuation of cell growth in the larval fatbody (Figures 2 and 3). As
described above, the subcellular distribution of FKH in starved
animals is in stark contrast to the one of dFOXO, which is
predominantly nuclear in this nutritional state. Another apparent
difference between the shuttling of FKH and dFOXO is that in the
case of dFOXO, both the overexpressed and endogenous protein
translocates to the cytoplasm upon insulin stimulation of cells. This
likewise holds true for the mammalian FOXOproteins. The situation
f o rF O X Ap r o t e i n sa p p e a r st ob es o m e w h a tl e s su n i f o r m .W er e p o r t
forthefly FOXA/FKH thattheendogenousprotein isexcludedfrom
the nuclei in the larval fatbody under conditions of highly abundant
dietary protein and amino acids, which translates into high TOR
signaling activity. In contrast, overexpressed FKH protein is
constitutively nuclear even on a high protein diet. The cause for
this may be that the abundance of one or several upstream regulators
is limiting and tuned to endogenous FKH concentrations. If the copy
number of FKH protein is elevated beyond physiological levels, it
may escape negative regulation and nuclear export induced by the
endogenous signaling components, and thus accumulate in the
Figure 6. FKH is required for the response to rapamycin and lowered TOR levels. Realtime qPCR was performed to quantify mRNAs in
larval extracts. (A) Transcription of CG6770 and cabut is induced upon rapamycin treatment (Rapa) and downregulated in larvae with low FKH levels
(w; arm-Gal4/+; UAS-FKH-RNAi/+). Compared to rapamycin-fed wildtype and unspecific control animals (w; arm-Gal4/+; UAS-LacZ-RNAi/+), expression
of CG6770 and cabut is significantly lower in rapamycin-fed FKH-RNAi larvae. (B) Consistent with the high expression of CG6770 and cabut in
rapamycin-treated larvae, these genes are transcriptionally upregulated in dTOR mutants (y w; dTOR
DP/+ and y w; dTOR
DP/dTOR
DP). The elevated
expression is suppressed in larvae transheterozygous for dTOR and FKH (y w; dTOR
DP/+; fkh
1/+ and y w; dTOR
DP/+; fkh
6/+), indicating that FKH function
is required for target gene induction by low TOR signaling. (C) The body weight of adult flies heterozygous for dTOR
DP is increased by the presence of
one copy of the fkh
1 allele. Both male and female transheterozygous flies are slightly but significantly heavier than dTOR
DP/+ flies. Significance was
tested using an unpaired 2-tailed Student’s t-test. *=p,0.05; **=p,0.01; ***=p,0.001. Error bars represent SEM.
doi:10.1371/journal.pone.0015171.g006
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insulin-dependent nucleocytoplasmic shuttling of FOXO proteins is
well established [3]. Also mouse Foxa2 has been shown to translocate
to the cytoplasm under conditions of high insulin signaling in cultured
cells as well as in tissues such as liver and hypothalamus [32,33,34],
but there have been conflicting reports arguing that hepatic Foxa2 is
constitutively nuclear, irrespective of metabolic state or insulin levels
[35,36]. It remains to be investigated whether the regulation of
Drosophila FKH localization and activity by TORC1 described here is
conserved in mammalian orthologs such as Foxa2. Conversely, it
remains to be investigated whether the TOR-dependent nuclear
exclusion of FKH is a consequence of protein phosphorylation.
Cytoplasmic sequestration of mouse Foxa2 is linked to phosphory-
lation of T156 by AKT, a residue within a sequence motif that is
conserved in Drosophila FKH [34]. In the light of our study and the
interactionofFoxA/PHA-4withTORandS6KinC.elegans[11], it is
also tempting to speculate that FoxA proteins may be regulated
through phosphorylation by TOR or S6K.
d4E-BP has been previously described as a target of dFOXO
[30,31]. We have demonstrated that d4E-BP expression is silenced
Figure7. FKH and TOR impact on the expression of the dFOXO target d4E-BP. Realtime qPCR was applied to quantify mRNAs in larval extracts.
(A) Compared to wildtype and unspecific control animals, transcript levels of d4E-BP are low in larvae expressing FKH dsRNA (w; arm-Gal4/+; UAS-FKH-
RNAi/+) and high in larvae overexpressing FKH (w;; ppl-Gal4/UAS-FKH). d4E-BP is upregulated in larvae treated with rapamycin, and the elevated d4E-BP
transcriptionresultingfromrapamycinfeedingiscompletelysuppressedbyFKHRNAi.(B) d4E-BPisupregulatedindTORmutants (yw;dTOR
DP/+andyw;
dTOR
DP/dTOR
DP) and the expression is suppressed in larvae transheterozygous for dTOR and FKH mutations (y w; dTOR
DP/+; fkh
1/+ and y w; dTOR
DP/+;
fkh
6/+). This suggests that d4E-BP is a transcriptional target not only of the insulin pathway and dFOXO, but also of the TOR pathway and FKH.
Significance was tested using an unpaired 2-tailed Student’s t-test. *=p,0,05 **=p,0,01 ***=p,0,001. Error bars represent SEM.
doi:10.1371/journal.pone.0015171.g007
Figure 8. A simplified working model of nutrient-dependent gene expression by TOR and FKH. (A) Under conditions of dietary protein
abundance, the TOR signaling module is active and exerts a negative regulation on FKH, which is consequently sequestered in the cytoplasm and
unable to modulate gene transcription. (B) When TOR complex 1 activity is inhibited by rapamycin or protein deprivation, the repression of FKH
activity is diminished. A significant fraction of the cellular FKH pool accumulates in the nucleus and activates expression of the growth-inhibiting
genes CG6770, cabut and d4E-BP.
doi:10.1371/journal.pone.0015171.g008
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Moreover, 4E-BP transcript levels are elevated upon pharmaco-
logical or genetic inactivation of TOR. As with the FKH target
genes cabut and CG6770, the positive effect of rapamycin or TOR
mutation on 4E-BP expression is suppressed by FKH knockdown
or FKH loss-of-function mutations. We therefore argue that d4E-
BP is most likely a common transcriptional target of both dFOXO
and FKH and thus constitutes an additional point of crosstalk
between the insulin and TOR signaling modules. The fact that
FKH and dFOXO share the conserved forkhead DNA binding
domain may suggest at least partially overlapping target gene
populations. Regarding the growth-suppressive action of FKH
under conditions of nutrient deprivation, it is currently unclear
whether growth inhibition is mainly achieved through the induction
of CG6770, cabut and d4E-BP or if other, yet unidentified FKH
targets also contribute to this phenotype. d4E-BP mutants have no
overgrowth phenotypeunder normal conditions [37], but it remains
to be investigated whether they display impaired growth inhibition
under starvation conditions. The observation that the Thor
1 allele
partially suppresses the Akt1 cell number phenotype in the eye
provides evidence that d4E-BP function is required when insulin
signaling levels are lowered [30]. In cultured cells, knockdown of
CG6770 [29] or cabut [25] leads to increased cell size, raising the
possibility that they also act as negative regulators of growth
downstream of FKH. Further studies are required to assess the
relative relevance of the individual target genes in this context.
In summary, we present the first evidence that the interaction
between TOR signaling and FoxA proteins is conserved in
Drosophila. Our study supports a model in which FKH is regulated
by the TOR pathway and dFOXO by the insulin/PI3K pathway,
two signaling systems that are already interwoven at several points
suchasTSC2and4E-BP.Ontheleveloftranscriptionfactors,there
seems to be differential regulation: FKH is activated under
conditions of protein deprivation and low TOR signaling, while
dFOXO is activated by complete starvation and low insulin
signaling. However, there is also a downstream node of conver-
gence. The expression of the translational inhibitor d4E-BP, which
has been established as a dFOXO target and is transcriptionally
induced by protein deprivation as well as complete starvation [27],
is induced under conditions of low TOR signaling by FKH. This
emerging molecular scenario outlined by these observations would
allow cells and organisms to react specifically to different conditions
of nutrient availability and food composition.
Materials and Methods
Constructs, antibodies and fly lines
The open reading frames (ORFs) encoding FKH (a protein
comprising 510 amino acid residues) and dFOXO (a protein
comprising 613 amino acid residues) were PCR-amplified from
genomic DNA (fkh is a single-exon gene) isolated from adult flies
and from a pUAST-dFOXO plasmid template [30], respectively.
The amplicons were cloned into pENTR/D-TOPO (Invitrogen)
to generate gateway entry constructs, which were fully sequenced
to ensure sequence integrity. Cell culture expression constructs
were then created by transferring the ORFs via LR recombination
into the modified gateway destination vector pAHW-Blast, which
corresponds to the pAHW plasmid from Terence Murphy’s
Drosophila Gateway Vector Collection [38] with a blasticidin
resistance cassette cloned into the backbone, and allows expression
of N-terminally 3xHA-tagged proteins under control of the
Actin5C promoter. Furthermore, a pAGW-FKH construct was
generated to allow expression of a green fluorescent EGFP-FKH
fusion protein. P-element based expression constructs for trans-
genic flies were created by transferring the fkh ORF into pTHW
and pTRW from the same vector collection. The resulting
plasmids pTHW-FKH and pTRW-FKH allow GAL4-induced
expression of 3xHA-FKH and red fluorescent mRFP1-FKH,
respectively. An inverted repeat construct for the targeted in vivo
knockdown of FKH by RNAi was created by first PCR-amplifying
the first 701 bp of the fkh ORF with a XhoI linker added to the
forward and a BglII linker to the reverse primer. The resulting
amplicon was digested with XhoI and then self-ligated with T4
DNA ligase. The correct 1.4 kb ligation product was gel purified,
digested with BglII and cloned into the BglII site of pMF3 [39].
The cloning step was performed in SURE bacteria (Stratagene).
The CG6770 reporter plasmid pGL3-CG6770 was constructed by
cloning a 880 bp PCR amplicon covering the CG6770 regulatory
region up to the translation start codon into the pGL3-Basic vector
containing the gene encoding Photinus pyralis (firefly) luciferase
(Promega) as a BglII/blunt fragment. pGL3-Basic was first
digested with NcoI, the resulting 59 overhangs were then blunted
with T4 DNA polymerase before proceeding with BglII digestion
as the second step. The PCR was performed with a 59-
phosphorylated reverse primer to ensure efficient ligation by T4
DNA ligase. The control construct for expressing Renilla reniformis
luciferase under control of the RpIII128 promoter, polIII-RL [40],
was a kind gift of Norbert Perrimon. Phusion DNA polymerase
(Finnzymes) was used for all PCR steps in this study. All primer
sequences are provided as supporting information in Text S1. A
polyclonal antibody against FKH was generated by Coring
Systems Diagnostix (Gernsheim, D). aFKH1 was raised in rabbit
against the peptide SHSSLEATSPGKKD, and purified by
immunoaffinity chromatography. The location of the peptide in
the FKH protein sequence is provided as supporting information
in Text S3. Two independent transgenic UAS-FKH-RNAi lines
were mainly used. One was established with our pMF3-FKH
construct described above, and one was obtained from the
Transgenic RNAi Project (TRiP) at Harvard Medical School
(TRiP stock JF02417) [41]. A third construct which was generated
by cloning a 913 bp amplicon spanning part of the fkh ORF and
part of the fkh 39-UTR into the Sym-pUAST-w vector [42] was
found to be less effective in inducing in vivo knockdown compared
to the other two constructs (data not shown), and was therefore not
further used in most experiments. The regions in the fkh mRNA
which are targeted by the three individual RNAi constructs are
provided as supporting information in Text S2. All in vivo RNAi
experiments which involved knockdown of FKH expression were
performed in parallel with transgenics carrying the pMF3
construct or the TRiP construct, and identical phenotypes were
observed for both. The loss-of-function allele dTOR
DP, which is a
deletion generated by imprecise P-element excision and removes
the dTOR translation start site as well as the amino-terminal 902
codons [14], was a gift of Tom Neufeld. The fkh loss-of-function
alleles fkh
1 (stock nr. 3331) and fkh
6 (stock nr. 545) were obtained
from the Bloomington Drosophila Stock Center. fkh
1 contains an
ethyl methanesulfonate (EMS)-induced point mutation changing
the codon for W254, a residue in the forkhead DNA-binding
domain, into a stop codon, while the X-ray-induced allele fkh
6
carries an 11 bp deletion which produces a frameshift after the
codon for residue E7 [15]. FKH overexpression in vivo was
achieved by use of transgenic UAS-3xHA-FKH or UAS-mRFP1-
FKH lines which were established with our pTHW-FKH and
pTRW-FKH constructs.
Larval starvation and rapamycin feeding
If not stated otherwise, embryos were collected for 4 h on PBS-
agar plates with yeast paste (prepared by suspending one cube of
Regulation of Drosophila FKH/FOXA by TOR
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Figure 2 are derived from larvae that were treated as follows: for
the ‘‘yeast’’ condition, larvae were kept on yeast paste until 64 h
AED. For the ‘‘PBS’’ condition, larvae were kept on yeast paste
until 64 h AED, washed out of the yeast paste, rinsed with water
and transferred to a petri dish with PBS-soaked filter paper for
another 24 h. For the ‘‘rapamycin’’ condition, larvae were kept on
yeast paste until 48 h AED, before 200 mlo fa5 0mM rapamycin
(LC Laboratories) solution was added to the yeast paste and the
plates were further incubated for 24 h at 25uC.
Immunohistochemistry
Antibody stainings were performed as described before [43]. In
brief, larval tissues were dissected in Drosophila Ringer’s solution
and fixed for 309 in 4% formaldehyde in PBS+0.5% Tween-20
(PBT). Tissue was blocked with 5% Goat Serum in PBT for 309,
and washed before and after incubation with primary antibody in
PBS+0,5% Tween-20 or PBS+0.1% Tween-20, respectively, for
5/5/15/309. Incubation with primary antibodies diluted in
blocking solution was performed over night at 4uC. Fluores-
cence-coupled secondary antibodies were applied for 1 h at RT.
DAPI (1 mg/ml) was included in the last washing step before
samples were mounted in Mowiol (Roth). Primary antibodies used
were rabbit aFKH1 (dilution 1:200), mouse anti-GFP (Sigma,
dilution 1:500), guinea pig anti-ppl (a gift of Ingo Zinke, dilution
1:500) and mouse anti-CD2 (Serotec, dilution 1:200). Secondary
antibodies (all diluted 1:200 in PBS+0.1% Tween-20+5% Goat
Serum) used were Alexa Fluor 488 goat anti-mouse IgG and Alexa
Fluor 546 goat anti-rabbit IgG (Invitrogen) and Cy5 anti-guinea
pig (Jackson ImmunoResearch). Mounted tissue was analyzed
using a Zeiss LSM 710 confocal microscope and images were
further processed with the Zeiss LSM Image Software. The size of
cell clones in fatbody samples was measured using the ImageJ
software.
Cell culture and luciferase assays
Drosophila S2R+ cells were obtained from the Drosophila
Genomics Resource Center (DGRC stock nr. 150), cultured at
25uC in Schneider’s Drosophila medium (Invitrogen) containing
10% heat-inactivated FCS (Sigma). Cells were split and diluted to
a density of 1610
6 per ml once per week. For reporter gene assays,
S2R+ cells were transfected with the FuGene HD reagent (Roche)
in 24 well-plates (Greiner). Per well, 50 ng of the reporter
construct pGL3-CG6770 and 5 ng polIII-RL were used. Where
indicated, 200 ng of expression plasmids pAHW-FKH-Blast or
pAHW-dFOXO-Blast were co-transfected with the reporter gene
constructs. After the cells had grown in the multiwell plates to a
density of ca. 80%, transfection was performed for 8 h, after which
cells were allowed to recover on serum-containing medium for
12 h and subsequently subjected to serum deprivation over night.
Cells were lysed in Passive Lysis Buffer before measuring firefly
and Renilla luciferase activities subsequently in each sample
according to the Dual Luciferase System protocol (Promega) in a
Wallac luminometer (PerkinElmer). The firefly luciferase values
were normalized to the Renilla values to account for variations in
transient transfection efficiency.
Realtime PCR
Quantitative realtime PCR to measure transcript levels was
done as described previously [20]. Briefly, total RNA was
extracted from Drosophila larvae with TriFast (peqlab)/chloroform
in a Precellys homogenisator (peqlab), following the manufactur-
er’s protocol. Extracted RNA was dissolved in DEPC-treated
water. To minimize RNA degradation, RNA was stored at 280uC
and used as a template for cDNA synthesis within 24 h. 1 mgo f
total RNA was used for cDNA synthesis with the QuantiTect kit
(Qiagen). cDNA integrity and absence of contamination by
genomic DNA was assessed by a PCR amplification of Actin5C
from + and 2 reverse transcriptase reactions. Realtime qPCR was
performed with a CFX96 instrument (Bio-Rad). Primers were
designed with the GC-content recommended for qPCR (between
40% and 60%) and low self-complementarity using the software
tool Primer3. Prior to quantitation experiments, primer efficiency
and NTC (No Template Control) was tested for each primer pair
to ensure an efficiency of at least 80% and rule out primer dimer
formation. PCR reactions consisted of first-strand cDNA template
and iQ SYBR Green Supermix (Biorad). Actin5C and rp49
transcript levels were used for normalization. All primer sequences
are provided as supporting information in Text S1. For every
mRNA quantitation, the minimal number of replicates consisted
of biological triplicates, with each triplicate measured twice as
technical replicates for a total of six measurements.
Statistics
Error bars represent the standard error of the mean (SEM) if not
stated otherwise. Statistical significance was assessed using an
unpaired two-tailed Student’s t-test, comparing the experimental
data with the respective controls. For comparisons between one
experimental value and two control values (such as wildtype and
unspecific RNAi controls), analysis of variance (ANOVA) was used
in addition to confirm the significance values derived from the
pairwise t-tests. If not stated otherwise, all experiments were
carried out at least twice independently. Asterisks indicate a p-
value of ,0.05 (*), ,0.01 (**) or ,0.001 (***). Significance was
tested with the software InStat 3 from GraphPad Software.
Supporting Information
Figure S1 Efficiency of RNAi-mediated knockdown. fkh mRNA
levels were quantified in larval extracts by quantitative realtime
PCR to control RNAi-mediated knockdown. Compared to wild-
type larvae, expression of fkh dsRNA (pMF3-fkh construct) under
control of the armadillo driver lead to a reduction of fkh transcript
levels by 60%. Heterozygosity for the fkh
1 allele reduced larval
transcript levels by 70% compared to wildtype animals.
(TIF)
Figure S2 Control of antibody specificity and localization of
overexpressed FKH. FKH is the main protein recognized by the
newly generated aFKH1 antibody in western blots and immuno-
stainings, and overexpressed FKH is constitutively nuclear. (A)
Western blot analysis of larval extracts probed with the aFKH1
antibody. Lane 1: in an extract from wild-type larvae, the antibody
detects a single protein band of approximately 54 kDa, which is the
predicted molecular weight of FKH and therefore most likely
corresponds to endogenous FKH. Lane 2: in an extract from w;
UAS-mRFP1-FKH; ppl-GAL4 larvae, the 54 kDa protein is detected
as well. In addition, a band of higher molecular weight is visible
which corresponds to the transgenically encoded mRFP1-FKH
fusion protein. (B–E) Immunofluorescent double staining of fatbody
from y w hs-FLP;; Act.CD2.Gal4 UAS-GFPnls/UAS-3xHA-FKH
larvae. The GFP-marked cell clones express transgenically encoded
3xHA-tagged FKH protein, which is recognized by a mouse
monoclonal anti-HA antibody (B) as well as the rabbit polyclonal
aFKH1 antibody (D). Secondary antibodies used were anti-mouse-
Cy3 and anti-rabbit-Cy5. For both antibodies, one panel shows the
only the signal of the actual immunostaining (B and D), panel C
shows the merged signals of the clone marker GFP and and the
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channels. Also when both stainings are performed separately on
different batches of tissue from larvae of the indicated genotype, the
nuclear 3xHA-FKH is detected by aFKH1 as well as anti-HA (data
not shown). This demonstrates that aFKH1 is a suitable tool to
visualizeFKHinimmunostainings,andthatthemain nuclearsignal
detected by the antibody corresponds to FKH protein and not an
unspecific protein recognized by the antibody. In contrast to the
endogenousprotein (see figure 4),overexpressed FKHis localized in
the nucleus also under conditions of high TOR and insulin
signaling. The fatbody shown in panels B–E is from a population of
larvae which had been reared on protein-rich yeast paste,
nevertheless the overexpressed 3xHA-FKH protein is nuclear. We
also investigated the subcellular localization of overexpressed
fluorescent FKH fusion proteins in cultured cells. (F–H) In S2R+
cells that had been transiently co-transfected with pAct5C-GAL4
and pTRW-FKH and were growing in serum-containing medium,
the red fluorescent mRFP1-FKH protein is localized in the cell
nuclei. (I–K) Likewise, in S2R+ cells that had been transiently
transfected with pAGW-FKH, were growing in serum-containing
medium and had been furthermore stimulated with 100 nM bovine
insulin for 20 min., the green fluorescent EGFP-FKH is nuclear.
Panels F and I show the signal of the respective fluorescent FKH
fusion proteins, panelsG and J theDAPI DNAstainings of thesame
confocal sections, and H and K the merged pictures containing
signals from both channels. The same nuclear localization was
observed in cells that had either been treated with 20 nM
rapamycin for 30 min. or serum-deprived over night and
subsequently subjected to PI3K inhibition with 50 mM LY294002
for 1 h (data not shown).
(TIF)
Figure S3 Induction of CG6770 promoter activity by FKH.
Over-expressed FKH protein activates transcription from the
CG6770 promoter in cultured cells. S2R+ cells were transiently
tranfected with a reporter plasmid containing the firefly luciferase
gene under control of the CG6770 regulatory region. The Renilla
luciferase construct polIII-RL was co-transfected as an internal
control to compensate for well-to-well variation in transfection
efficiency. Before lysis and luciferase measurements, cells were
incubated in serum-free medium over night to lower growth factor
signaling levels. Compared to cells transfected with the luciferase
vectors only, co-transfection of the dFOXO expression plasmid
pAHW-dFOXO-Blast lead to a several fold induction of luciferase
expression from the CG6770 promoter. Expression of FKH by co-
transfection with pAHW-FKH-Blast elicited a much stronger
induction of the reporter construct, leading to luciferase levels that
were 5 fold higher than in the dFOXO-expressing cells and 20 fold
higher compared to the control cells without expression vector.
(TIF)
Figure S4 Correlation with TSC1/2 and Rheb gain-of-function
phenotypes. Inhibition or activation of TOR signaling leads to
similar phenotypes as FKH overexpression and knockdown,
respectively. (A and C) On a protein-rich yeast paste diet, co-
expression of TSC1 and TSC2 in cell clones in the larval fatbody
leads to a strong reduction in cell size. (B) The growth-inhibiting
effect of TSC1/2 expression is much less pronounced in starved
animals. (D) Conversely, activation of TOR signaling by
expression of the small GTPase Rheb (Saucedo et al., 2003;
Stocker et al., 2003) has a very mild growth-promoting effect on a
protein-rich diet and (E and F) a stronger one under conditions of
starvation. The same driver line was used as in the experiments
shown in figure 2. A similar correlation was observed when using
the expression of FKH target gene candidates as a readout. (G)
Like FKH knockdown, expression of Rheb (driven by arm-Gal4)
silences transcription of CG6770 and d4E-BP. Inhibition of TOR
signaling by TSC1/2 expression (driven by ppl-Gal4) leads to a
strong elevation of mRNA levels of both genes, as does FKH
expression. These observations further strengthen our model that
FKH is functionally linked to the TOR signaling module.
(TIF)
Text S1 Sequences of primers used in this study.
(PDF)
Text S2 Regions in the fkh mRNA sequence targeted by the
individual RNAi constructs used.
(PDF)
Text S3 Location of the peptide used for antibody generation
within the FKH protein sequence.
(PDF)
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